← back to search

Federica Mescia

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia ·
🔎 Find collaborators in Infectious Diseases · Pulmonary and Respiratory Medicine →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Infectious Diseases · Pulmonary and Respiratory Medicine
Research interest
Research interests include SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, Vasculitis and related conditions, and Renal Diseases and Glomerulopathies.
h-index
25
citations
8,995
works
95
NIH funding
—
primary concept
Medicine
email
✉ Find email ↗

Recent publications

Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity
Nature 2022cited by 1,160position: middledoi
Predictors of hypogammaglobulinemia in ANCA-associated vasculitis after a rituximab-based induction: a multicentre study
Lara D. Veeken 2022cited by 28position: middledoi
Coagulation factor V is a T-cell inhibitor expressed by leukocytes in COVID-19
iScience 2022cited by 10position: middledoi
Author Correction: SARS-CoV-2 evolution during treatment of chronic infection
Nature 2022cited by 6position: middledoi
Author Correction: Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies
Nature 2022cited by 3position: middledoi
SARS-CoV-2 evolution during treatment of chronic infection
Nature 2021cited by 1,077position: middledoi
Single-cell multi-omics analysis of the immune response in COVID-19
Nature Medicine 2021cited by 822position: middledoi
Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies
Nature 2021cited by 713position: middledoi
A thermostable, closed SARS-CoV-2 spike protein trimer
Nature Structural & Molecular Biology 2020cited by 358position: middledoi
Combined Point-of-Care Nucleic Acid and Antibody Testing for SARS-CoV-2 following Emergence of D614G Spike Variant
Cell Reports Medicine 2020cited by 82position: middledoi
Combined point of care SARS-CoV-2 nucleic acid and antibody testing in suspected moderate to severe COVID-19 disease
medRxiv 2020cited by 3position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

— · 1 papers (2022–2022)Federico Alberici · Brescia University1 papers (2022–2022)María C. Cid · Indiana University School of Medicine1 papers (2022–2022)— · 1 papers (2022–2022)David Jayne · University of Colorado Denver1 papers (2022–2022)— · 1 papers (2022–2022)Rona Smith · Cambridge University Hospitals NHS Foundation Trust1 papers (2022–2022)Vladimı́r Tesař · University Hospital Cologne1 papers (2022–2022)— · 1 papers (2022–2022)— · 1 papers (2022–2022)— · 1 papers (2022–2022)Maurizio Gallieni · The University of Texas Health Science Center at Houston1 papers (2022–2022)Annette Bruchfeld · Linköping University1 papers (2022–2022)— · 1 papers (2022–2022)Augusto Vaglio · Azienda Ospedaliero-Universitaria Careggi1 papers (2022–2022)— · 1 papers (2022–2022)Sophie Ohlsson · Lund University1 papers (2022–2022)— · 1 papers (2022–2022)Lorraine Harper · Cardiff University1 papers (2022–2022)Iva Gunnarsson · Karolinska University Hospital1 papers (2022–2022)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Infectious Diseases · Pulmonary and Respiratory Medicine →